- Home
- BMY vs ICE Comparison
BMY vs ICE Comparison
Compare BMY & ICE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BMY | ICE |
|---|---|---|
| Founded | 1887 | 2000 |
| Country | United States | United States |
| Employees | 32500 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 113.5B | 87.5B |
| IPO Year | N/A | 2013 |
Fundamental Metrics
Financial Performance| Metric | BMY | ICE |
|---|---|---|
| Price | $57.21 | $139.30 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 15 | 9 |
| Target Price | $61.73 | ★ $194.78 |
| AVG Volume (30 Days) | ★ 9.6M | 3.8M |
| Earning Date | 04-30-2026 | 04-30-2026 |
| Dividend Yield | ★ 4.38% | 1.33% |
| EPS Growth | N/A | ★ 20.71 |
| EPS | N/A | ★ 2.48 |
| Revenue | N/A | ★ $5,834,000,000.00 |
| Revenue This Year | N/A | $10.29 |
| Revenue Next Year | N/A | $4.76 |
| P/E Ratio | ★ $17.26 | $56.06 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $42.52 | $136.67 |
| 52 Week High | $62.89 | $189.35 |
Technical Indicators
Market Signals| Indicator | BMY | ICE |
|---|---|---|
| Relative Strength Index (RSI) | 51.68 | 31.89 |
| Support Level | $56.36 | $136.67 |
| Resistance Level | $60.50 | $161.54 |
| Average True Range (ATR) | 1.41 | 3.74 |
| MACD | 0.05 | -0.52 |
| Stochastic Oscillator | 51.82 | 14.84 |
Price Performance
Historical ComparisonAbout BMY Bristol-Myers Squibb Company
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
About ICE Intercontinental Exchange Inc.
Intercontinental Exchange is a vertically integrated operator of financial exchanges and provides ancillary data products. Though the company is probably best known for its ownership of the New York Stock Exchange, which it acquired in 2013, ICE operates a large derivatives exchange, too. The company's largest commodity futures product is the ICE Brent crude futures contract. In addition to the exchanges business, which is about 54% of net revenue, Intercontinental Exchange has used a series of acquisitions to create its mortgage technology business (22% of net revenue) and fixed-income and data-services segment (24% of net revenue).